EVALUATE THE SAFETY AND EFFICACY OF RELOXALIASE (OXALATE DECARBOXYLASE) IN PATIENTS WITH ENTERIC HYPEROXALURIA: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (URIROX-2)

Registry ID

ALLN-177-302

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

ALLENA PHARMACEUTICALS INC

Start date

2019-07-31

Last update

2019-07-10

Conditions

• HYPEROXALURIA

Related clinical trials

• PHASE 1-2A SAFETY, TOLERABILITY, AND PHARMACODYNAMICS CONTROLLED STUDY OF NOV-001 IN HEALTHY VOLUNTEERS AND PATIENTS WITH ENTERIC HYPEROXALURIA
• AN OPEN-LABEL ROLL-OVER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DCR-PHXC SOLUTION FOR INJECTION (SUBCUTANEOUS USE) IN PATIENTS WITH PRIMARY HYPEROXALURIA

View on source registry